Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis

Abstract

In adults with CRSwNP refractory to treatment with INCS alone, the addition of dupilumab reduced disease severity, significantly improved HRQoL, and improved productivity.